NCT03599635View on ClinicalTrials.gov

Pec Infiltration With Liposomal Bupivacaine for Breast Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

July 1, 2018

Primary Completion Date

July 1, 2024

Study Completion Date

July 1, 2024

Conditions
Acute Pain
Interventions
DRUG

liposomal bupivacaine

Experimental

DRUG

Bupivacaine

Active Comparator

Trial Locations (1)

55455

M Health Ambulatory Surgery Center, Minneapolis

All Listed Sponsors
lead

University of Minnesota

OTHER

NCT03599635 - Pec Infiltration With Liposomal Bupivacaine for Breast Surgery | Biotech Hunter | Biotech Hunter